03:06 AM EDT, 07/31/2026 (MT Newswires) -- French biopharmaceutical company DBV Technologies (DBV.PA) intends to raise $50 million through the sale of 3,657,644 American depositary shares to RA Capital Management. Each ADS represents five ordinary shares and will be issued at an at-the-market price of $13.67 each under the company's at-the-market program, according to a Thursday filing. The offering covers 18,288,220 new ordinary shares and is expected to settle Aug. 3.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.